Prevalence of pericardial effusion in autosomal dominant polycystic kidney disease

Johanna Sophia Jost1, Till Frederik Kaireit2, Bernd Auber3

  • 1Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.

Clinical Kidney Journal
|November 2, 2023
PubMed

Insights

Pericardial effusion (PE) affects 6.3% of autosomal dominant polycystic kidney disease (ADPKD) patients, with higher prevalence in females. Autoimmune diseases were more common in patients with PE, suggesting further investigation for non-ADPKD pathologies.

Area of Science:

  • Nephrology
  • Cardiology
  • Radiology

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is associated with various extrarenal manifestations.
  • Pericardial effusion (PE) is a potential underrecognized complication of ADPKD, with reported prevalence up to 35%.

Purpose of the Study:

  • To systematically evaluate the prevalence of PE in an ADPKD cohort outside the USA.
  • To identify associated risk factors for PE in ADPKD patients.

Main Methods:

  • Retrospective analysis of clinically stable ADPKD patients from a specialized outpatient clinic.
  • Evaluation of computed tomography (CT) and magnetic resonance imaging (MRI) scans for PE presence (≥4 mm).
  • Correlation of imaging findings with clinical characteristics.

Main Results:

  • Pericardial effusion (PE) was detected in 17 out of 208 evaluable ADPKD patients (8.2%), resulting in an overall prevalence of 6.3%.
  • PE prevalence was higher in females (7.8%) compared to males (3.8%).
  • Autoimmune diseases were more prevalent in patients with PE (11.8% vs. 2.1%, P=.022); no association was found with rapid disease progression, ADPKD genotype, age, or BMI.

Conclusions:

  • The prevalence of PE in this ADPKD cohort was lower than previously reported, with a notable female predominance.
  • Further attention to patients with PE >10 mm is warranted due to potential co-existing non-ADPKD pathologies.
  • Renal functional impairment, sex, and proteinuria are suggested as candidate variables for further investigation.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
10
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
11
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
9